Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Biosimilars
The Pharmacy Times® Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy.
Latest News
Understand Patient Experiences With Biosimilar Transitions
May 6th 2024
Study participants’ overall satisfaction with a mandatory nationwide adalimumab transition in New Zealand varied but was generally low.
